Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics

Keyphrases

• Systemic Treatment 100%
• Systemic Antibiotics 100%
• Intravitreal 100%
• Bacterial Endophthalmitis 100%
• Antibiotics 33%
• Inflammation 33%
• Operative 33%
• Systemic Administration 33%
• Disease Severity 33%
• Therapeutic Levels 33%
• Inappropriate Treatment 33%
• Vancomycin 33%
• PubMed Search 33%
• Systemic Antibiotic Therapy 33%
• Antibiotic Concentration 33%
• Moxifloxacin 33%
• Eye Conditions 33%
• Guidance Documents 33%
• Rifampicin 33%
• Meropenem 33%
• Ciprofloxacin 33%
• Ceftazidime 33%
• Antibiotic Regimen 33%
• Levofloxacin 33%
• Trimethoprim-sulfamethoxazole (TMP-SMX) 33%
• Cefepime 33%
• Ceftriaxone 33%
• Piperacillin 33%
• Imipenem 33%
• Daptomycin 33%
• Aminoglycosides 33%
• Clarithromycin 33%
• Linezolid 33%
• Systemic Antibiotic Treatment 33%
• Aminopenicillin 33%
• Antibiotic Alternatives 33%
• Evidence-based Prescribing 33%
• Microbiological Aspects 33%
• Cefazoline 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antibiotics 100%
• Endophthalmitis 100%
• Systemic Treatment 100%
• Antibiotic Therapy 33%
• Inflammation 33%
• Vancomycin 33%
• Cefazolin 33%
• Moxifloxacin 33%
• Rifampicin 33%
• Meropenem 33%
• Ciprofloxacin 33%
• Ceftazidime 33%
• Levofloxacin 33%
• Cotrimoxazole 33%
• Systemic Administration 33%
• Cefepime 33%
• Ceftriaxone 33%
• Piperacillin 33%
• Aminoglycoside 33%
• Clarithromycin 33%
• Imipenem 33%
• Linezolid 33%
• Daptomycin 33%
• Aminopenicillin 33%
• Diseases 33%